Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics vs Placebo for Uncomplicated Appendicitis (APPAC III)
NCT03234296Enrolling by invitation
- Sponsor
- Turku University Hospital
- Start
- Aug 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ertapenem, levofloxacin and metronidazole in acute appendicitis, sponsored by Turku University Hospital. Primary endpoint: Success of the randomized treatment at 10 days. Started Aug 2017; status: enrolling by invitation.
02
Drugs
ertapenemlevofloxacinmetronidazole
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT03234296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234296.